Presentation:
Stimulation Plus: The process of activating or encouraging a biological or chemical response in a system.
An ADMET predictor is a software tool used in drug discovery to forecast how a chemical compound will behave in the human body, specifically measuring its Absorption, Distribution, Metabolism, Excretion, and Toxicity.
Advantage: Reduces Animal Testing
Disadvantage: Limited Accuracy & Misses Complex Interactions
Reason : Relies on computer models (in silico), which can yield false positives or negatives and fail to mimic complex biology perfectly.
Broad Endpoint Portfolio – A comprehensive collection of different biological endpoints used to evaluate a drug’s effects and safety.
Advantages :Gives a more complete drug evaluation.
Disadvantages: Can be time-consuming and complex & development cost
Gastro Plus Integration: Integration of Gastro Plus to predict and analyze a drug’s absorption, distribution, metabolism, and pharmacokinetic behavior.
Advantage: Helps predict drug behavior in the human body before clinical testing.
Disadvantage: Requires accurate input data and can be computationally complex.
Optibrium is a specialized software and artificial intelligence company that provides tools to optimize and accelerate the drug discovery process. { R&D sector, design, analyze, and select potential new drug compounds}
Reason:
Biopharmics: 3D molecular modeling software used to simulate how potential drugs interact with biological targets.
Stardrop :ADMET -Def.
Adavantage: Advantage: Multi-Parameter Optimization (MPO){ StarDrop excels at evaluating potential drug compounds against multiple critical criteria simultaneously (such as potency, safety, and metabolic stability)}
Disadvantage: Disadvantage: High Complexity and Learning Curve{ platform is highly sophisticated, requiring deep domain expertise in cheminformatics, structural biology, and data science to properly configure models}
ADME-QSAR Module: A computational tool that predicts a drug’s Absorption, Distribution, Metabolism, and Excretion (ADME) properties using molecular structure and QSAR models.[Quantitative Structure Activity Relationship]
Advantage: Helps predict drug activity quickly without extensive laboratory testing.

Disadvantage: Predictions may be inaccurate if the model is trained on limited or poor-quality data.
Auto-Modeller is a specialized automation module within Optibrium’s StarDrop software suite.{ It allows researchers to automatically build, train, and validate customized machine learning models }
Advantage: some generated are so complex that it is difficult for a scientist to understand the underlying biological mechanism
Disadvantage: Auto-Modeller is its heavy reliance on high-quality internal training data ("garbage in, garbage out").
 Schrödinger employs a dual strategy. 
QikProp provides rapid, physics-inspired empirical descriptors for approximately 60 properties (logP, logS, permeability).
AutoQSAR utilizes deep multitask graph convolutional networks for larger datasets (>5,000 compounds), allowing for high-resolution off-target toxicity screening.

Toxometris	Ensemble ML	50+ Endpoints, OECD-compliant, Genotoxicity	Commercial Cloud	Web API, QMRF Output
ADMETlab 3.0	DMPNN-Des Framework	119 Features: Hematotoxicity, Nephrotoxicity, Neurotoxicity, HLM Stability	Free Web/API	Web Portal, REST API
StarDrop	QSAR (RF, GP, PLS)	Physchem, ADME, Multi-objective SAR	Commercial Desktop	GUI, Plugin support
ADMET Predictor 12	ML (ANN, RF, PLS)	Physchem, SOM, Toxicity (Ames, hERG), HLM Clearance	Commercial Desktop	GUI, CLI, REST API

Random Forest is a machine learning algorithm that combines multiple decision trees to make accurate predictions by combining their output.
Deep2Lead is a deep-learning-based virtual screening tool used to identify and prioritize promising drug candidates (lead compounds) from large chemical databases.
Advantages:Helps identify potential lead molecules efficiently.
Disadvantage:Requires large, high-quality training datasets for accurate predictions.
Uncertainty and Domain of Applicability
Aleatoric and Epistemic Uncertainty: ADMETlab 3.0 distinguishes itself by using evidential deep learning to capture both aleatoric (data noise) and epistemic (model knowledge) uncertainty.
Applicability Domains: ADMET Predictor provides explicit applicability flags, whereas StarDrop and QikProp require significant analyst judgment to determine if a molecule sits within a valid chemical space.
QSAR Modelling: Predicts a chemical compound’s properties or biological activity from its molecular structure.
Physico-empirical Equations: Use physical properties and experimental data to mathematically predict drug behavior.
Multi-task Learning: A machine learning method that learns multiple related tasks simultaneously using shared information.
Lipophilicity (LogP/LogD): Measures how easily a drug dissolves in fat compared with water.
Solubility (LogS): Measures how well a drug dissolves in a solvent, usually water.pKa (Acidic/Basic): Indicates the pH at which a drug is 50% ionized and 50% unionized.
Polar Surface Area (PSA): Measures the surface area of a molecule contributed by its polar atoms.
Caco-2/MDCK Permeability: Measures how easily a drug passes through cell membranes.
Blood-Brain Barrier (BBB): Predicts whether a drug can cross the protective barrier between blood and the brain.
CYP Inhibition/Substrate: Predicts whether a drug inh: 'ts or is metabolized by CYP enzymes.

Human Intestinal Absorption (HIA):
Predicts how much of an orally administered drug is absorbed through the intestine.Ames Mutagenicity: Predicts whether a compound can cause genetic mutations.
hERG Inhibition: Predicts whether a drug may block hERG potassium channels, which can affect heart rhythm.
Hepatotoxicity (DILI): Predicts whether a drug can cause liver injury.
Genotoxixity: Predicts whether a compound can damage DNA or genetic material.

Drug-likeness Rules: Guidelines used to assess whether a compound has properties suitable for becoming an effective drug.
Structural Alerts (PAINS): Chemical structures that may cause false-positive results in biological screening.
Metabolic Stability: Measures how resistant a drug is to being chemically broken down by the body.
Typical R² (0.6–0.8): Indicates how well a model’s predictions match the observed experimental values.
Classification Accuracy (70–85%): Shows the percentage of samples correctly classified by the model.
Applicability Domain: Defines the range of compounds for which a model can make reliable predictions.
Uncertainty Estimation: Quantifies how uncertain or reliable a model’s prediction is.
Confidence Scores: Indicates the model’s level of confidence in a prediction.
In-house vs. Vendor Models: Compares a locally developed model with models provided by external vendors.
Leaderboard Rankings: Compares model performance based on standardized evaluation metrics.
New Approach Methodologies (NAMs): Modern testing methods that can reduce or replace traditional animal testing.
Reducing Animal Testing: Uses alternative methods to minimize the need for animal experiments.
AI-Powered Evaluators: AI-based tools that assess drug safety and biological effects using computational prediction.
OECD Principles: International guidelines that promote reliable and scientifically valid testing methods.
QMRF Documentation: A standardized document describing the quality, methodology, and reliability of a QSAR model.
ICH M7 Requirements: Guidelines for assessing and controlling DNA-reactive impurities that may pose a mutagenic risk.

Transparency and Trust: Makes Al predictions understandable so users can see how and why a result was produced.
Bias Management: Identifies and reduces unfair or systematic biases in Al predictions.
Feature Visualizations: Visual representations showing which input features contribut prediction an Al model's.

Multi-modal Data: Combines different types of data, such as molecular, biological, and clinical information.
Generative Al Design: Uses Al to generate or optimize new molecular structures with desired properties.
Real-World Evidence: Uses data from real-world healthcare settings to support evaluation of drugs and treatments.
